Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2024

Open Access 01-12-2024 | Ruxolitinib | Case report

Acute invasive fungal sinusitis with orbital tip syndrome in patients on long-term use of ruxolitinib: a case report

Authors: Zhiyuan Tang, Zhaohui Shi

Published in: Journal of Medical Case Reports | Issue 1/2024

Login to get access

Abstract

Introduction

A long-term ruxolitinib-treated patient with primary myelofibrosis, who was co-infected with aspergillosis infection during a short period, developed acute invasive fungal sinusitis with consequent orbit apex syndrome. This may be the first reported case in the world.
This is a 75-year-old Chinese man; the patient was admitted with 2-month history of headache accompanied by numbness and 8-day history of vision loss. The preliminary clinical diagnoses were suspected acute invasive fungal sinusitis or adenoid cystic carcinoma. We performed endoscopic debridement and antifungal therapy. About 90 days after surgery, magnetic resonance imaging revealed no recurrence of pathological tissue.

Conclusion

One of the bases for the occurrence of invasive fungal sinusitis may be the patient’s long-term use of ruxolitinib for essential thrombocythemia. Some patients with invasive fungal sinuses have atypical nasal symptoms and are referred to the corresponding departments with eye and headache as the first symptoms. It is suggested that enhanced magnetic resonance imaging should be performed at an early stage. Surgical treatment in combination with antifungal and enhanced immunotherapy can effectively prevent the spread of infection and reduce the risk of death.
Literature
2.
3.
go back to reference Barbui T, Thiele J, Gisslinger H, Finazzi G, Vannucchi AM, Tefferi A. The 2016 revision of WHO classification of myeloproliferative neoplasms: clinical and molecular advances. Blood Rev. 2016;30:453–9.CrossRefPubMed Barbui T, Thiele J, Gisslinger H, Finazzi G, Vannucchi AM, Tefferi A. The 2016 revision of WHO classification of myeloproliferative neoplasms: clinical and molecular advances. Blood Rev. 2016;30:453–9.CrossRefPubMed
4.
go back to reference Hultcrantz M, Ravn Landtblom A, Andreasson B, Samuelsson J, Dickman PW, Kristinsson SY, et al. Incidence of myeloproliferative neoplasms—trends by subgroup and age in a population-based study in Sweden. J Intern Med. 2020;287:448–54.CrossRefPubMedPubMedCentral Hultcrantz M, Ravn Landtblom A, Andreasson B, Samuelsson J, Dickman PW, Kristinsson SY, et al. Incidence of myeloproliferative neoplasms—trends by subgroup and age in a population-based study in Sweden. J Intern Med. 2020;287:448–54.CrossRefPubMedPubMedCentral
5.
go back to reference McLornan DP, Khan AA, Harrison CN. Immunological consequences of JAK inhibition: friend or foe? Curr Hematol Malig Rep. 2015;10(4):370–9.CrossRefPubMed McLornan DP, Khan AA, Harrison CN. Immunological consequences of JAK inhibition: friend or foe? Curr Hematol Malig Rep. 2015;10(4):370–9.CrossRefPubMed
6.
go back to reference Quintas-Cardama A, Kantarjian H, Cortes J, et al. Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond. Nat Rev Drug Discov. 2011;10(2):127–40.CrossRefPubMed Quintas-Cardama A, Kantarjian H, Cortes J, et al. Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond. Nat Rev Drug Discov. 2011;10(2):127–40.CrossRefPubMed
7.
go back to reference Heine A, Brossart P, Wolf D. Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis? Blood. 2013;122(23):3843–4.CrossRefPubMed Heine A, Brossart P, Wolf D. Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis? Blood. 2013;122(23):3843–4.CrossRefPubMed
8.
go back to reference Heine A, Held SA, Daecke SN, et al. The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. Blood. 2013;122(7):1192–202.CrossRefPubMed Heine A, Held SA, Daecke SN, et al. The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. Blood. 2013;122(7):1192–202.CrossRefPubMed
9.
go back to reference Lussana FD, Ianni M, Rambaldi A. Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation? Bone Marrow Transplant. 2017;52:1225–32.CrossRefPubMed Lussana FD, Ianni M, Rambaldi A. Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation? Bone Marrow Transplant. 2017;52:1225–32.CrossRefPubMed
10.
go back to reference Massa M, Rosti V, Campanelli R, et al. Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib. Leukemia. 2014;28(2):449–51.CrossRefPubMed Massa M, Rosti V, Campanelli R, et al. Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib. Leukemia. 2014;28(2):449–51.CrossRefPubMed
12.
go back to reference Miyamoto Y, Sakamoto Y, Ohuchi M, Tokunaga R, Shigaki H, Kurashige J, Iwatsuki M, Baba Y, Yoshida N, Watanabe M, Baba H. Orbital apex syndrome caused by invasive aspergillosis as an adverse effect of systemic chemotherapy for metastatic colorectal cancer: a case report. Anticancer Res. 2016;36(2):821–3.PubMed Miyamoto Y, Sakamoto Y, Ohuchi M, Tokunaga R, Shigaki H, Kurashige J, Iwatsuki M, Baba Y, Yoshida N, Watanabe M, Baba H. Orbital apex syndrome caused by invasive aspergillosis as an adverse effect of systemic chemotherapy for metastatic colorectal cancer: a case report. Anticancer Res. 2016;36(2):821–3.PubMed
13.
go back to reference Willermain F, Bradstreet C, Kampouridis S, et al. Different presentations of ophthalmic aspergillosis. Eur J Ophthalmol. 2008;18(5):827–30.CrossRefPubMed Willermain F, Bradstreet C, Kampouridis S, et al. Different presentations of ophthalmic aspergillosis. Eur J Ophthalmol. 2008;18(5):827–30.CrossRefPubMed
16.
go back to reference Biswas SS, Al-Amin Z, Razib FA, Mahbub S. Acute invasive fungal rhinosinusitis: our experience in immunocompromised host. Mymensingh Med J. 2013;22(4):814–9.PubMed Biswas SS, Al-Amin Z, Razib FA, Mahbub S. Acute invasive fungal rhinosinusitis: our experience in immunocompromised host. Mymensingh Med J. 2013;22(4):814–9.PubMed
Metadata
Title
Acute invasive fungal sinusitis with orbital tip syndrome in patients on long-term use of ruxolitinib: a case report
Authors
Zhiyuan Tang
Zhaohui Shi
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04486-3

Other articles of this Issue 1/2024

Journal of Medical Case Reports 1/2024 Go to the issue